Bacillus Calmette-Guérin: from TB prophylaxis to tumour Immunotherapy

The use of BCG is best known as a vaccination against tuberculosis. However, its role in bladder cancer immunotherapy goes back almost four decades, and its success has prompted increasing interest in the manipulation of the immune system against tumours.

This story is Premium Content and is only available to registered users. Please log in to view the full text. If you don't already have an account, please register with us completely free of charge.

Upcoming Events

SHOT Report 2019: ADU highlights webinar

Online
28 January 2021

COVID-19 - The Infection that Challenged the World: Is Necessity the Mother of Invention?

Online
11-14 May 2021

Lab Innovations 2021

NEC, Birmingham
3-4 November 2021

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022

Upcoming Events

SHOT Report 2019: ADU highlights webinar

Online
28 January 2021

COVID-19 - The Infection that Challenged the World: Is Necessity the Mother of Invention?

Online
11-14 May 2021

Lab Innovations 2021

NEC, Birmingham
3-4 November 2021

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022